KorPath
KorPath is a national high-complexity CLIA-certified anatomical and molecular pathology laboratory in Tampa, FL, serving specialty physician practices, LTC/SNF chains, wound care clinics, and hospitals with 24-48 hour turnaround and PCR-based molecular pathogen detection through partner Vanta Diagnostics.
- Company typePrivate
- Founded-
- HeadquartersTampa, United States
- Headcount251–500
- GTM typeB2B
- OfferingServices
What KorPath does
KorPath is a national high-complexity CLIA-certified anatomical pathology laboratory headquartered in Tampa, Florida, operating as a brand under Verify Diagnostics LLC alongside partner lab Vanta Diagnostics and affiliated entity Korgene. The company delivers a full diagnostic menu spanning dermatopathology, gastrointestinal pathology, non-GYN cytology, podiatric pathology, surgical pathology, urologic pathology, ENFD (Epidermal Nerve Fiber Density) testing for small fiber peripheral neuropathy, and immunofluorescence services for autoimmune bullous and connective tissue diseases. Its core technology combines traditional subspecialty anatomical pathology expertise with PCR-based molecular pathogen detection panels (WOUND-ID, URINE-ID, RESPIRA-ID, DERM-ID, NAIL-ID, VAGINAL-ID, COVID-19, pharmacogenetics) offered through Vanta Diagnostics, including detection of 49 antibiotic resistance genes and integrated PharmD-guided antibiotic stewardship consultation, plus mobile telepathology frozen section services in Florida.
KorPath serves specialty physician practices in dermatology, podiatry, urology, gastroenterology, and primary care; multi-site long-term care and skilled nursing facility chains; wound care specialists; infectious disease and urgent care providers; and hospitals and ambulatory surgery centers across the United States, with select international specimen work. The business model is transaction-based fee-for-service, billing Medicare, Medicaid, and commercial insurance under the Medicare Clinical Laboratory Fee Schedule, supplemented by a direct patient online payment portal. Go-to-market is sales-led, combining direct field representatives enrolling physician accounts, structured enterprise account management for multi-site healthcare organizations, EMR/EHR integrations, provider portals (LabTests.io, Agillaire Orv), and active participation in specialty medical society conferences across podiatry, dermatology, urology, wound care, and long-term care. KorPath competes on 24-48 hour turnaround, subspecialty pathologist expertise (150+ combined years, 300+ publications), and clinical decision support layered onto diagnostic output.
KorPath firmographics
Firmographics- Name
- KorPath
- Legal name
- Verify Diagnostics LLC
- Website
- https://korpath.com
- Company type
- Private
- Operating status
- Operating
- Headcount range
- 251–500 employees
- Short description
- KorPath is a national high-complexity CLIA-certified anatomical and molecular pathology laboratory in Tampa, FL, serving specialty physician practices, LTC/SNF chains, wound care clinics, and hospitals with 24-48 hour turnaround and PCR-based molecular pathogen detection through partner Vanta Diagnostics.
- Ownership category
- akta.pro rank
KorPath industry classification
Industry- Product category
- Diagnostic Pathology Laboratory Services
- NAICS
- Medical Laboratories (621511), Medical and Diagnostic Laboratories (6215), Medical and Diagnostic Laboratories (62151)
- SIC
- Services-Medical Laboratories (8071)
- akta.pro primary industry
- Point-of-Care Testing (POCT) & Near-Patient Labs (HLAFAMAI)
- akta.pro secondary industries
- Central Laboratory & Clinical Trial Testing CROs (HLAGAAAE), Clinical Trial Sample Collection & Site Phlebotomy Services (HLAGACAJ)
Keywords
Where KorPath is headquartered
LocationHeadquarters
- HQ city
- Tampa
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
KorPath business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Supply Chain, Technology or R&D, Marketing or Sales
Revenue model
- Clinical Laboratory Diagnostic Services: KorPath operates as a clinical laboratory billing Medicare, Medicaid, and commercial insurance for diagnostic testing services. Laboratory services billed to Medicare are paid based on the Clinical Laboratory Fee Schedule. Tests are ordered by treating physicians and billed to payors; patients may be billed directly for statutorily excluded services or when advance beneficiary notices of noncoverage are secured.
- Patient Direct Payments: Online payment portal for patients to pay invoices or submit deposits via credit card. SSL-encrypted processing with email receipts; credit card details are not stored in the system.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Transaction based/ take rate | Pay-as-you-go | Diagnostic testing services billed to Medicare, Medicaid, and commercial insurance |
Go-to-market motion2 records
Distribution channels5 records
Marketing channels5 records
KorPath product offering
Product offeringCore offering
KorPath is a national high-complexity CLIA-certified laboratory in Tampa, FL providing full anatomical pathology services (dermatopathology, GI, urologic, podiatric, surgical pathology, non-GYN cytology, ENFD, immunofluorescence) and, via partner lab Vanta Diagnostics, molecular diagnostic panels for rapid pathogen and antibiotic-resistance detection. It bills payors for physician-ordered diagnostic testing with 24-48 hour turnaround.
Product overview
KorPath is a national high-complexity CLIA-certified anatomical pathology laboratory in Tampa, FL, providing a full array of diagnostic services. The core offering consists of anatomical pathology services including dermatopathology, gastrointestinal pathology, non-GYN cytology, podiatry, surgical pathology, urologic pathology, ENFD testing for peripheral neuropathy, and immunofluorescence services for autoimmune diseases. KorPath operates in partnership with Vanta Diagnostics (formerly Vikor Scientific), which provides molecular pathology services including URINE-ID, RESPIRA-ID, DERM-ID, WOUND-ID, NAIL-ID, VAGINAL-ID, COVID-19, and pharmacogenetics testing. The molecular diagnostic panels offer rapid pathogen detection with 12-24 hour turnaround and antibiotic resistance gene testing. KorPath also offers mobile telepathology frozen section services in Florida. The company emphasizes 24-48 hour turnaround times and consultative services with over 150 years of combined pathologist experience.
Differentiator
Problem solved
Functional benefit
Products and services
- Anatomical Pathology Services Full anatomical pathology laboratory services including dermatopathology, gastrointestinal pathology, non-GYN cytology, podiatry, surgical pathology, and urologic pathology, with 24-48 hour turnaround and telepathology support, for specialty physician practices.
- Vanta Diagnostics Molecular Pathology Services Molecular diagnostic testing through partner lab Vanta Diagnostics offering customized panels for rapid pathogen detection, semi-quantification, and resistance gene identification within 12-24 hours of specimen arrival, for physicians and infectious disease providers.
- ENFD (Epidermal Nerve Fiber Density) Testing Small fiber peripheral neuropathy diagnostic test using a 3mm punch biopsy to quantify and evaluate integrity of terminal branches of peripheral nerves within the epidermis, detecting conditions associated with metabolic, inherited, toxic, autoimmune, and infectious disorders.
- Immunofluorescence Services (DIF/IIF) Direct and indirect immunofluorescence testing for diagnosis of autoimmune bullous diseases, vasculitis, connective tissue diseases, and related skin conditions using Michel's fixative transport media.
- Mobile Telepathology Frozen Section Services Mobile frozen section service in Florida providing a fully staffed mobile unit with histotechnologist and board-certified pathologist to process and interpret frozen sections via telepathology within minutes at physician offices.
- WOUND-ID Testing Molecular diagnostic panel for wound infections detecting bacteria, fungi, viruses, and 49 antibiotic resistance genes with PharmD guidance for targeted antibiotic selection, for wound care specialists and long-term care facilities.
- URINE-ID Testing Molecular diagnostic panel for urinary pathogen detection and quantification.
- RESPIRA-ID Testing Molecular diagnostic panel for respiratory pathogen detection.
- DERM-ID Testing Molecular diagnostic panel for dermatological pathogen detection to aid in diagnosis of skin infections with atypical presentations.
- NAIL-ID Testing Molecular diagnostic panel using PCR technology for rapid nail fungal and bacterial infection diagnosis, more sensitive and specific than conventional culture methods.
- VAGINAL-ID Testing Molecular diagnostic panel for vaginal pathogen detection.
- COVID-19 Testing Molecular diagnostic testing services for COVID-19 detection.
- Pharmacogenetics Testing Genetic testing service for personalized medication selection and dosing recommendations based on patient pharmacogenomic profiles.
- Dermatopathology Services Consultative dermatopathology service including diagnosis of skin cancers (malignant melanoma, basal cell carcinoma, squamous cell carcinoma), atypical nevi, seborrheic keratosis, actinic keratosis, and immunofluorescence testing for autoimmune skin diseases.
Quantifiable outcome
- 24-48 hour turnaround time on all pathology services
- +4 more outcomes
Companies that use KorPath
Customer profileNamed customers7 records
Segments4 records
Ideal customer profiles3 records
KorPath technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration3 records
AI capability3 records
Feature6 records
KorPath partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Vanta Diagnostics (formerly Vikor Scientific)coreKorPath's partner lab Vanta Diagnostics (formerly Vikor Scientific) focuses on molecular diagnostic testing and develops customized pathogen panels for molecular diagnostics. KorPath offers Vanta's molecular testing menu (URINE-ID, RESPIRA-ID, DERM-ID, WOUND-ID, NAIL-ID, VAGINAL-ID, COVID-19, PHARMACOGENETICS) as part of its service offering, and both companies share the Verify Diagnostics compliance and branding infrastructure. KorPath and Vanta together operate under the Verify Diagnostics family of laboratories. Molecular supply orders are placed through Vanta Diagnostics' website.
Scale indicators5 records
Recent moves6 records
Expansion highlights5 records
KorPath competitors and assessment
Company assessmentDirect peers
- Quest Diagnostics: Largest US clinical reference laboratory offering nationwide anatomical pathology, molecular infectious-disease testing, and routine diagnostics — directly competing with KorPath across dermatopathology, urology, wound care, and physician-office specimen logistics.
- Laboratory Corporation of America (LabCorp): National reference laboratory with full anatomical pathology and molecular diagnostics menu; competes head-to-head with KorPath for specialty physician office accounts and LTC/SNF specimen volume.
- PathGroup: Physician-led anatomical and clinical pathology provider in the Southeast US with similar specialty practice focus (dermatopathology, GI, urology) — closely comparable to KorPath in customer mix and regional footprint.
- Inform Diagnostics: Specialty anatomical pathology laboratory with deep dermatopathology, GI, and urology sub-specialty expertise; competes for the same specialty physician customers that drive KorPath's volume.
- DermPath Diagnostics: Dermatopathology-focused laboratory serving dermatology practices nationally; directly overlaps with KorPath's highest-volume specialty (dermatopathology) and immunofluorescence offerings.
Broad incumbents
- Sonic Healthcare USA: Global pathology and laboratory services operator with US presence including anatomical pathology, molecular diagnostics, and reference lab services — competes at the national, multi-specialty level.
- ARUP Laboratories: Academic-affiliated national reference laboratory with deep specialty pathology and esoteric molecular testing menus; overlaps with KorPath on complex dermatopathology and ENFD-style specialty assays.
- BioReference Laboratories (OPKO Health): National full-service clinical and molecular diagnostic laboratory serving physicians, hospitals, and health systems — competes with KorPath in routine and specialty molecular testing.
- Cleveland Clinic Laboratories / Cleveland Clinic Pathology: Academic medical center reference laboratory offering specialty anatomical pathology and molecular testing to external clients; comparable on specialty diagnostics and subspecialty pathologist expertise.
- Mayo Clinic Laboratories: National esoteric reference laboratory within Mayo Clinic offering specialty pathology, molecular, and esoteric assays; competes for high-complexity specialty work similar to KorPath's ENFD and immunofluorescence menu.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks5 records
Key highlights7 records
Customer concentration
KorPath social profiles
Digital presenceKorPath compliance and trust
Trust signalCompliance1 record
KorPath financial estimates
Financial estimateRevenue estimate
Valuation estimate
KorPath leadership team
Management profileNumber of profiles
Profiles4 records
KorPath funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
KorPath M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about KorPath
What does KorPath do?
KorPath is a national high-complexity CLIA-certified laboratory in Tampa, FL providing full anatomical pathology services (dermatopathology, GI, urologic, podiatric, surgical pathology, non-GYN cytology, ENFD, immunofluorescence) and, via partner lab Vanta Diagnostics, molecular diagnostic panels for rapid pathogen and antibiotic-resistance detection. It bills payors for physician-ordered diagnostic testing with 24-48 hour turnaround.
Is KorPath a public or private company?
KorPath is a private company. It is classified as corporate owned and is currently operating.
When was KorPath founded?
KorPath was founded in -1. It employs 251 to 500 people.
Where is KorPath based?
KorPath is headquartered in Tampa, United States, in the North America region.
How does KorPath make money?
Two revenue lines are on record. Clinical Laboratory Diagnostic Services are the primary driver. The others are patient Direct Payments.
Who are KorPath's main competitors?
Direct peers on record are Quest Diagnostics, Laboratory Corporation of America (LabCorp), PathGroup, Inform Diagnostics and DermPath Diagnostics. Broad incumbents are Sonic Healthcare USA, ARUP Laboratories, BioReference Laboratories (OPKO Health), Cleveland Clinic Laboratories / Cleveland Clinic Pathology and Mayo Clinic Laboratories.
Does KorPath have an API?
No public API is recorded for KorPath.
What industry is KorPath in?
KorPath's product category is Diagnostic Pathology Laboratory Services. Its primary akta.pro industry code is HLAFAMAI, Point-of-Care Testing (POCT) & Near-Patient Labs, with a secondary code of HLAGAAAE, Central Laboratory & Clinical Trial Testing CROs. Its NAICS code is 621511 and its SIC code is 8071.